Found: 4
Select item for more details and to access through your institution.
PCSK9 Inhibitors in a German Single-Center Clinical Practice: Real-World Treatment of Patients at High Cardiovascular Risk Over 68 Weeks.
- Published in:
- American Journal of Cardiovascular Drugs, 2021, v. 21, n. 1, p. 83, doi. 10.1007/s40256-020-00411-3
- By:
- Publication type:
- Article
Severe hypertriglyceridemia in a patient heterozygous for a lipoprotein lipase gene allele with two novel missense variants.
- Published in:
- European Journal of Human Genetics, 2015, v. 23, n. 9, p. 1259, doi. 10.1038/ejhg.2014.295
- By:
- Publication type:
- Article
Mutation spectrum and polygenic score in German patients with familial hypercholesterolemia.
- Published in:
- Clinical Genetics, 2020, v. 98, n. 5, p. 457, doi. 10.1111/cge.13826
- By:
- Publication type:
- Article
size of apolipoprotein (a) is an independent determinant of the reduction in lipoprotein (a) induced by PCSK9 inhibitors.
- Published in:
- Cardiovascular Research, 2022, v. 118, n. 9, p. 2103, doi. 10.1093/cvr/cvab247
- By:
- Publication type:
- Article